ArticleNature communications2015

ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.

Kei Miyakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.